Company intelligence / Profile preview

Methapharm

Cambridge, Ontario, Canada

Ownership: Private
Employees: ~56
Development stage: Commercial

Overview

Methapharm commercializes specialty pharmaceutical and diagnostic products in North America and globally. Its respiratory diagnostics portfolio includes Provocholine® (methacholine), Aridol® (mannitol), and Vivatmo pro for FeNO measurement—tools recommended by international guidelines for asthma diagnosis. The company partners with global firms to expand its product reach. No clinical trial results are published as the main offerings are approved diagnostics or drugs already on the market.

Therapeutic areas: PulmonologyOther
Modalities: Small molecules (e.g., methacholine for bronchial challenge tests)Diagnostic agents (e.g., mannitol for bronchial challenge, FeNO measurement devices)
Industry: Metabolite Diagnostics

Partnerships

Partners with leading international pharmaceutical companies to market/distribute products in North America; specific partner names not disclosed.

Beyond the preview

Go deeper on Methapharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Methapharm.

Explore the full profile